Consortia for Improving Medicine with Innovation and Technology (CIMIT)
CIMIT accelerates innovation in healthcare by facilitating collaboration among clinicians, healthcare managers, technologists, engineers, and entrepreneurs to develop and implement leading-edge products, services, and procedures that improve patient care.
The Consortia for Improving Medicine integrates talented and inquiring minds from academia, healthcare, engineering labs, scientific research and industry.
Our Growing Network
CIMIT was formed in 1998 as a “center without walls,” linking four leading academic research centers in the greater Boston area.
It now includes 13 of Boston’s strongest academic medical centers, universities, and a growing network of national and international affiliates. Starting from a foundation in medical devices, diagnostics, and procedures, the scope has grown to address the full spectrum of medical innovation including e-health, drugs, and biologics.
Founders:
- Brigham & Women’s Hospital
- Massachusetts General Hospital
- Charles Stark Draper Laboratory
- Massachusetts Institute of Technology
Members:
- Beth Israel Deaconess Medical Center
- Boston Children’s Hospital
- Boston Medical Center
- Boston University
- Harvard Medical School
- Newton-Wellesley Hospital
- Northeastern University
- Mass General Brigham
- VA Boston Healthcare System
National Affiliates:
- Yale University
- New England Pediatric Device Consortium
- Boston Biomedical Innovation Center
- Point-of-Care Technologies Research Network
International Affiliates:
- Agency for Science, Technology and Research
- Eastern Health Alliance
- NHS England
- Madrid-MIT M+Vision Consortium
- Oxford Academic Health Science Network
- Health Innovation Manchester
Long-term Commitment to Dual-Benefit Innovations with the DoD
Since its founding, CIMIT has had a highly productive relationship with the US Department of Defense, sharing the mission to address the healthcare needs of warfighters as well as civilians resulting in dual-benefit solutions. Much of CIMIT's early, and part of its ongoing, funding has been from the US Army Medical Research and Materiel Command.